Hepatocellular Carcinoma

Direct-acting Antivirals Cut Mortality In Chronic Hepatitis C

TUESDAY, Feb. 12, 2019 -- For adults with chronic hepatitis C virus (HCV) infection, direct-acting antivirals are associated with a reduced risk for mortality and hepatocellular carcinoma, according to a study published online Feb. 11 in The...
Related topics: Hepatitis, Hepatitis C, Virus, Virology, Medical Research

Read More →

Hep C Antivirals Tied To Lower Mortality And Cancer Risk

(MedPage Today) -- 52% drop in all-cause mortality, 34% drop in hepatocellular carcinoma cases
Related topics: Cancer, Oncology

Read More →

Direct-acting Antivirals Not Tied To Liver Cancer Recurrence

FRIDAY, Jan. 25, 2019 -- Direct-acting antiviral (DAA) therapy is not associated with increased overall or early hepatocellular carcinoma (HCC) recurrence among patients with a previous complete response to HCC treatment, according to a study...
Related topics: Liver Cancer, Cancer, Oncology, Medical Research

Read More →

Nus And Harvard Scientists Develop Novel Drug That Could Potentially Treat Liver Cancer More...

A research team led by scientists from the Cancer Institute of Singapore at the National University of Singapore has developed a novel peptide drug called FFW that could potentially stop the development of hepatocellular carcinoma or primary liver...
Related topics: Harvard University, Liver Cancer, Cancer, Oncology, Medical Research

Read More →

Roche's Tecentriq Gets Breakthrough Therapy Status For Hcc

Roche Holding AG RHHBY announced that the FDA has granted breakthrough therapy designation to its immuno-oncology drug, Tecentriq, in combination with Avastin for the first-line treatment of advanced hepatocellular carcinoma (HCC).The...
Related topics: Food And Drug Administration, Cancer, Oncology, Avastin

Read More →

Exelixis Slides Despite Positive Late-stage Results

Shares of Exelixis slipped on Wednesday after the company reported results from its late-stage trial of cabozantinib for advanced hepatocellular carcinoma.

Read More →

Bristol-myers' Opdivo Gets Priority Review For Liver Cancer

Bristol-Myers Squibb Company BMY announced that the FDA has accepted and granted a priority review designation to the supplemental Biologics License Application (sBLA) for the label expansion of Opdivo (nivolumab) to patients with hepatocellular...
Related topics: Bristol-Myers Squibb, Liver Cancer, Cancer, Oncology, Food And Drug Administration

Read More →

One More Piece In The Puzzle Of Liver Cancer Identified

Scientists are one step closer to unraveling the mechanisms behind liver cancer. The researchers discovered that RAF1, a protein known as an oncogene in other systems, unexpectedly acts as a tumour suppressor in hepatocellular carcinoma.
Related topics: Liver Cancer, Cancer, Oncology, Medical Research, Proteins

Read More →

Nccn Awards 3 Grants To Investigators To Study Bavituximab In Combination With Other Therapeutic...

The NCCN Oncology Research Program has awarded research grants to three investigators to study bavituximab in glioblastoma, head and neck cancer, and hepatocellular carcinoma.
Related topics: Medical Research, Cancer, Oncology, Glioblastoma

Read More →

New Hepatocellular Carcinoma Prognostic Model Improves Prediction Of Patient Survival

The ITA.LI.CA prognostic system, a model integrating tumor staging, liver function, functional status, and alpha-fetoprotein level, builds on previous models of hepatocellular carcinoma (HCC) prognosis and shows superior survival prediction in...
Related topics: Cancer, Liver Cancer

Read More →

Towards The Goal Of Precision Therapy In Hepatocellular Carcinoma

Hepatocellular carcinoma is a highly lethal disease, therefore effective and tolerable treatment is urgently needed. Authors of a new report provide an updated review of the genetic abnormalities and mechanisms that drive carcinogenesis of HCC, and...
Related topics: Genetics

Read More →

Scientists Root Out The 'bad Seeds' Of Liver Cancer

USC researchers have discovered the Achilles heel of hepatocellular carcinoma, a leading cause of cancer deaths worldwide.
Related topics: Liver Cancer, Cancer, Oncology, Medical Research

Read More →

Screening For Hepatocellular Carcinoma

Learn the risk factors for hepatocellular carcinoma, and who to screen, how often to screen, and what tools should be used. Medscape Gastroenterology

Read More →

Medical News Today: Outreach Invitations Boost Hcc Screening In Cirrhosis Patients

New research presented at a conference in Paris suggests outreach interventions may increase screening for hepatocellular carcinoma in patients with cirrhosis.
Related topics: Cirrhosis, Medical Research

Read More →

Key Factor Discovered In Progression Of Liver Cancer

One of the most aggressive and common forms of liver cancer is hepatocellular carcinoma. A team of researchers has now identified the crucial key factor involved in the development and progression of this malignant type of tumour: the AXL receptor...
Related topics: Medical Research, Liver Cancer, Cancer, Oncology

Read More →

Bayer/amgen's Nexavar Fails In Late-stage Study - Analyst Blog

The HealthCare segment at Bayer (BAYRY) and partner, Amgen Inc. (AMGN), announced disappointing results from a phase III STORM (Sorafenib as Adjuvant Treatment in the Prevention of Recurrence of Hepatocellular Carcinoma) study on Nexavar. The...
Related topics: Amgen

Read More →

Fda Approves New Phase Iii Trial For Celesion's Thermodox

The FDA has cleared Celesion's (CLSN +6.35%) Optima Phase III trial of its ThermoDox therapy for treating hepatocellular carcinoma (HCC), the most common type of liver cancer. In a previous late-stage study, called Heat, ThermoDox failed...
Related topics: Food And Drug Administration, Liver Cancer, Cancer, Oncology

Read More →

Gene Deficiency In Males 'could Cause Diabetes And Liver Cancer'

Scientists have discovered a genetic deficiency in males that could prompt the development of the most common type of liver cancer - hepatocellular carcinoma - and type 2 diabetes. This is according to a study published in the journal Cancer...
Related topics: Genetics, Diabetes, Type 2 Diabetes, Liver Cancer, Cancer, Medical Research, Oncology

Read More →

Researchers Identify Liver Cancer Progenitor Cells Before Tumors Become Visible

For the first time, researchers at the University of California, San Diego School of Medicine have isolated and characterized the progenitor cells that eventually give rise to malignant hepatocellular carcinoma (HCC) tumors - the most common form of...
Related topics: Liver Cancer, Cancer, Oncology

Read More →

Low Fat Intake Is Associated With Pathological Manifestations And Poor Recovery In Patients With...

Background: This study aimed to clarify whether dietary deviation is associated with pathological manifestations in hepatocellular carcinoma (HCC) patients. Methods: Dietary intake was estimated in 35 HCC cases before and after hospitalization by...

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.